Page last updated: 2024-08-26

cv 3988 and Cornea Injuries

cv 3988 has been researched along with Cornea Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, IW; Jung, WK; Lee, CM; Lee, DS; Lee, YM; Na, G; Park, SG; Park, WS; Seo, SK; Yang, JW; Yea, SS1
Bazan, HE; Tao, Y1

Other Studies

2 other study(ies) available for cv 3988 and Cornea Injuries

ArticleYear
Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
    Cutaneous and ocular toxicology, 2015, Volume: 34, Issue:1

    Topics: Alkalies; Animals; Cell Movement; Cells, Cultured; Corneal Injuries; Corneal Neovascularization; Corneal Opacity; Eye Burns; Female; Ginkgolides; Human Umbilical Vein Endothelial Cells; Humans; Lactones; Mice; Neovascularization, Physiologic; Neutrophils; Phospholipid Ethers; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger

2015
PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:3

    Topics: Azepines; Cornea; Corneal Injuries; Diterpenes; Enzyme Activation; Epithelium; Extracellular Matrix Proteins; Fibrinolytic Agents; Ginkgolides; Lactones; Metalloendopeptidases; Phospholipid Ethers; Platelet Activating Factor; Thienopyridines; Triazoles; Urokinase-Type Plasminogen Activator; Wound Healing

1997